Zacks.com on MSN1h
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC
Merck MRK announced that the FDA has granted breakthrough therapy designation (BTD) to sacituzumab tirumotecan (sac-TMT) for ...
Pancreatic cancer patient survival doubled with high dose of common vitamin, study finds
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
John Wayne’s 1956 epic flop 'gave almost 100 people cancer' including Duke himself
John Wayne was very unhappy with his 1956 epic flop, which is not only considered one of the worst movies of all time but ...
emjreviews.com7h
Lung Cancer Screening Benefits Limited for Smokers with Severe Airflow Limitation
A RECENT study examining the impact of airflow limitation (AL) on lung cancer (LC) screening outcomes suggests that the ...
Frontiers11h
Advancing Precision Medicine in Lung Cancer: Integrating Genomics, Liquid Biopsy and Novel Diagnostic Tools
Precision medicine in the context of lung cancer represents a transformative approach that integrates prevention, diagnosis, and treatment tailored to individual patient differences. This field ...
News Medical16h
New algorithm identifies tumor cells driving aggressive cancer growth
The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by Cancer Research UK-funded scientists from UCL and The Francis Crick ...
Merck Receives FDA Breakthrough Therapy Designation for Investigational Lung Cancer Treatment
Merck ( MRK, Financials) stated that sacituzumab tirumotecan (sac-TMT) was designated a Breakthrough Therapy by the FDA for advanced or metastatic nonsquamous non-small cell lung cancer with epidermal ...